FIG 4. Graph to show how injection pressures (that are in addition to the baseline intravascular pressures) in intranidal vessels i21 and i37 (when an injection is performed through AF1), and in vessel i12 (when an injection is performed through AF2) affect the risk of rupture of these vessels. Vessels i21 and i37 rupture (risk >100%) with high injection pressures